SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-065376
Filing Date
2023-03-09
Accepted
2023-03-09 08:27:31
Documents
14
Period of Report
2023-03-08
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d398766d8k.htm   iXBRL 8-K 49004
2 EX-3.1 d398766dex31.htm EX-3.1 18969
3 EX-3.2 d398766dex32.htm EX-3.2 110180
  Complete submission text file 0001193125-23-065376.txt   333957

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA fstx-20230308.xsd EX-101.SCH 2846
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE fstx-20230308_lab.xml EX-101.LAB 17911
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fstx-20230308_pre.xml EX-101.PRE 11231
8 EXTRACTED XBRL INSTANCE DOCUMENT d398766d8k_htm.xml XML 3440
Mailing Address 35 PARKWOOD DRIVE BABRAHAM RESEARCH CAMPUS CAMBRIDGE X0 CB22 3AT
Business Address 35 PARKWOOD DRIVE BABRAHAM RESEARCH CAMPUS CAMBRIDGE X0 CB22 3AT 44 1223 497400
F-star Therapeutics, Inc. (Filer) CIK: 0001566373 (see all company filings)

IRS No.: 522386345 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37718 | Film No.: 23718276
SIC: 2834 Pharmaceutical Preparations